Incyte Skin Disease Cream for Children Meets Main Study Goal

Incyte said on Tuesday its cream to treat a type of skin condition in children between the age of 2 to 12 met the primary goal in a late-stage study.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/994250?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?